Healthcare And Life Sciences

Healthcare and life sciences occupy a unique position within the economy, influencing not only public health outcomes but also research, innovation, manufacturing, employment, and economic growth. The sector encompasses hospitals, pharmaceuticals, biotechnology, medical devices, diagnostics, digital health, research institutions, and a rapidly growing ecosystem of health technology companies working to improve the delivery, accessibility, and quality of healthcare services.

India today is home to one of the world's largest healthcare and pharmaceutical ecosystems. The healthcare sector is estimated to support more than 7.5 million jobs directly, while creating millions of additional indirect employment opportunities across pharmaceuticals, medical devices, diagnostics, healthcare services, logistics, research, and allied industries. The sector has also emerged as a significant contributor to economic activity, with India's healthcare market expected to grow from approximately USD 180 billion in 2023 to over USD 320 billion by 2028, driven by rising healthcare demand, increasing incomes, urbanisation, and expanding access to healthcare services.

India's pharmaceutical industry is widely recognised for its role in supplying affordable medicines to global markets and is often referred to as the "Pharmacy of the World." The country is among the largest providers of generic medicines globally and continues to strengthen its position in pharmaceuticals, biotechnology, vaccine manufacturing, and medical research. At the same time, the medical devices and biotechnology sectors are witnessing increasing levels of investment, innovation, and policy attention as India seeks to build stronger domestic capabilities and enhance its global competitiveness.

Technology is increasingly becoming an integral component of healthcare delivery and life sciences innovation. Artificial intelligence, digital health platforms, telemedicine, electronic health records, wearable technologies, genomics, precision medicine, robotics, and data-driven healthcare solutions are reshaping how healthcare is delivered, monitored, and managed. Government initiatives such as the Ayushman Bharat Digital Mission are helping create the foundations for a more connected and digitally enabled healthcare ecosystem. These developments are creating opportunities to improve patient outcomes, expand healthcare access, strengthen disease surveillance, and enhance operational efficiency across the healthcare value chain.

Alongside these opportunities, important policy considerations are emerging across areas such as healthcare innovation, pharmaceutical regulation, biotechnology governance, medical device ecosystems, health data governance, clinical research, workforce development, healthcare accessibility, and the responsible adoption of emerging technologies. Similar discussions are taking place across major economies as governments seek to strengthen healthcare systems while encouraging innovation, investment, and scientific advancement.

These developments present a significant opportunity for India. As healthcare demand continues to grow and innovation accelerates, the focus is increasingly shifting towards building an ecosystem that supports quality healthcare delivery, scientific research, technological advancement, and long-term resilience. Achieving this will require continued collaboration between government, healthcare providers, researchers, industry, academia, investors, and civil society.

This is where proactive policy engagement becomes essential. The future of healthcare and life sciences will be shaped not only by scientific and technological breakthroughs, but also by the policy frameworks that influence innovation, investment, access, and adoption. NextEra Policy works at exactly this intersection, bringing together stakeholders from across the healthcare and life sciences ecosystem to help foster informed discussions and contribute to a resilient, innovative, and future-ready healthcare sector.

The NextEra Policy Committee on Healthcare and Life Sciences is dedicated to advancing informed, forward-looking, and evidence-based discussions on the policies that influence healthcare delivery, medical innovation, life sciences research, and public health outcomes. At its core, the Committee exists to provide a platform where healthcare providers, pharmaceutical companies, biotechnology firms, medical device manufacturers, researchers, academics, investors, startups, and policymakers can engage on issues shaping the future of the sector.

The Committee recognises that healthcare policy today extends far beyond the delivery of medical services alone. Advances in biotechnology, pharmaceuticals, medical devices, digital health, artificial intelligence, genomics, precision medicine, and healthcare infrastructure are increasingly influencing how healthcare systems operate and evolve. As scientific innovation accelerates and healthcare needs become more complex, informed policy engagement becomes essential to ensuring that innovation, accessibility, affordability, and quality develop in a balanced and complementary manner.

India's healthcare and life sciences ecosystem is undergoing significant transformation. Rising healthcare demand, increasing investments in healthcare infrastructure, rapid technological advancement, growing research capabilities, and a thriving health-tech ecosystem are creating new opportunities across the sector. At the same time, developments in digital health, telemedicine, health data management, biotechnology, and medical research are opening new avenues for improving patient outcomes and expanding access to quality healthcare services. The Committee believes that thoughtful policy frameworks can play an important role in supporting these developments while fostering innovation, investment, and long-term sectoral growth.

While many policy discussions begin only after challenges emerge, the Committee believes that the most effective policy engagement often starts much earlier. This philosophy lies at the heart of NextEra Policy's approach. The Committee continuously studies healthcare and life sciences developments across major jurisdictions, examining how governments, regulators, research institutions, healthcare providers, and industry leaders are responding to emerging opportunities and policy considerations. By understanding global developments before they become mainstream policy discussions in India, the Committee seeks to identify opportunities, anticipate challenges, and contribute constructively to future policy conversations.

Whether it is healthcare innovation, pharmaceutical policy, biotechnology regulation, digital health frameworks, medical device ecosystems, health data governance, clinical research, healthcare workforce development, public health preparedness, or emerging healthcare technologies, the Committee seeks to remain ahead of the policy curve rather than merely responding to it. Through policy papers, stakeholder consultations, research initiatives, surveys, roundtables, conferences, and structured engagement with relevant institutions, it strives to bring evidence, practical insights, and diverse stakeholder perspectives into every discussion.

The Committee also seeks to ensure that important healthcare and life sciences policy discussions are accessible to a wider audience. Through publications, thought leadership initiatives, workshops, and stakeholder engagement activities, it works to promote greater awareness and understanding of the opportunities, innovations, and policy developments shaping the future of healthcare.

As healthcare systems continue to evolve and scientific advancement accelerates, the Committee remains committed to ensuring that stakeholders are informed, represented, and engaged in the policy discussions shaping the future of healthcare and life sciences in India. The objective is not merely to respond to change, but to better understand it, prepare for it, and contribute constructively to the frameworks that will support a healthier, more innovative, and future-ready healthcare ecosystem.

The NextEra Policy Committee on Healthcare and Life Sciences warmly welcomes new members at all times. If you believe in the importance of healthcare innovation, scientific advancement, evidence-based policymaking, and collaborative engagement, we would be delighted to have you join us on this journey.

1. What is the NextEra Policy Committee on Healthcare and Life Sciences?

The NextEra Policy Committee on Healthcare and Life Sciences is a dedicated platform that brings together healthcare providers, pharmaceutical companies, biotechnology firms, medical device manufacturers, researchers, academics, investors, startups, policymakers, and other stakeholders to engage on issues shaping the future of healthcare, medical innovation, and life sciences in India. The Committee works to promote informed policy discussions, develop evidence-based recommendations, and contribute to a healthcare ecosystem that supports innovation, accessibility, and long-term resilience.

2. Who can join the Committee?

The Committee welcomes hospitals, healthcare providers, pharmaceutical companies, biotechnology firms, medical device manufacturers, health-tech startups, research institutions, universities, investors, consultants, industry associations, policymakers, and professionals with an interest in healthcare and life sciences policy.

3. Do I need to have a medical or scientific background to become a member?

Not at all. Healthcare policy intersects with technology, innovation, investment, regulation, education, research, and public administration. The Committee welcomes diverse perspectives from business leaders, entrepreneurs, researchers, policymakers, consultants, investors, and professionals who engage with the healthcare ecosystem in their work.

4. What issues does the Committee focus on?

The Committee focuses on a broad range of issues including healthcare innovation, pharmaceutical policy, biotechnology, medical devices, digital health, telemedicine, artificial intelligence in healthcare, health data governance, clinical research, healthcare infrastructure, workforce development, public health preparedness, and emerging healthcare technologies.

5. What will I gain as a member of the Committee?

Members gain access to a network of healthcare leaders, researchers, policymakers, investors, industry experts, and innovators. They also have opportunities to contribute to policy discussions, participate in consultations and roundtables, engage in research initiatives, attend events, and stay informed about emerging developments affecting the healthcare and life sciences ecosystem.

6. How is the Committee different from other organisations working in the healthcare sector?

NextEra Policy's Committee is distinguished by its emphasis on proactive policy engagement. Rather than focusing solely on current regulatory issues, the Committee continuously studies global healthcare, biotechnology, and life sciences developments to identify opportunities, anticipate challenges, and contribute to policy discussions before they become mainstream concerns in India. The objective is not merely to react to change, but to help stakeholders prepare for it.

7. Why is policy engagement important in the healthcare and life sciences sector?

Policy frameworks influence healthcare accessibility, medical innovation, research ecosystems, pharmaceutical development, biotechnology growth, healthcare infrastructure, workforce readiness, and technology adoption. Effective policy engagement helps create an environment that supports innovation while ensuring quality, accessibility, safety, and long-term sustainability.

8. Will members have opportunities to engage with policymakers and sector experts?

Yes. The Committee facilitates engagement through consultations, policy dialogues, roundtables, conferences, working groups, research initiatives, and stakeholder discussions involving representatives from government, industry, academia, healthcare institutions, and the broader life sciences ecosystem.

9. How much time commitment does membership require?

The Committee is designed to be flexible and accessible. Members may participate in meetings, consultations, events, research projects, and working groups based on their interests and availability. There is no fixed time commitment, allowing members to engage at a level that suits their professional schedules.

10. How do I get started or learn more?

Getting started is simple. Reach out to us and we will guide you through the membership process, answer any questions you may have, and help you identify the best way to get involved.

For details, please write to us at director@nexterapolicy.in or fill in the membership form and a member of our team will get in touch with you shortly.